Odyssey Health, Inc.
Odyssey Health, Inc. (ODYY): 8 pipeline candidates · ~3 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
3.0 months
85% dilution
Lead: Phase 2
8 candidates
N/A
N/A
A transparent, data-derived signal for Odyssey Health, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$699K
Cash
$298K
Quarterly Burn
$319K
Runway
3.0 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (8 candidates)
| Drug | Phase |
|---|---|
| breastcheck | Preclinical |
| cardiomap | Preclinical |
| od-07656 | Phase 2 |
| onp-001 | Preclinical |
| onp-002 | Preclinical |
| save a life | Preclinical |
| save-a-life | Preclinical |
| vedolizumab | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Jun 2024Institutional holders
1
Total value held
$48K
| Holder | Shares | Value |
|---|---|---|
| orleans capital management corp/la | 1,000,000 | $48K |
Frequently asked questions
How many drug candidates are in Odyssey Health, Inc.'s pipeline?
Odyssey Health, Inc. (ODYY) has 8 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Odyssey Health, Inc.'s lead drug candidate?
Odyssey Health, Inc.'s most advanced tracked candidate is breastcheck (Preclinical) for non-invasive test for breast abnormalities.
What is Odyssey Health, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Odyssey Health, Inc. has approximately 3.0 months of cash runway.
What is Odyssey Health, Inc.'s market capitalization?
Odyssey Health, Inc.'s market capitalization is approximately $699K.
Who is the CEO of Odyssey Health, Inc.?
Mr. Joseph Michael Redmond is the chief executive officer of Odyssey Health, Inc. (ODYY).
Get the full picture on Odyssey Health, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.